SCHEMBL25724136

SCHEMBL25724136

CCc1cc2c(CC)c(C)ccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RXFP1 Q9HBX9 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
PRNP P04156 1/20 0.40
PPARG P37231 1/20 0.40
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NR2E3 Q9Y5X4 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MCL1 Q07820 1/20 0.39
SIRT1 Q96EB6 1/20 0.38
HTT P42858 2/20 0.38
PARP1 P09874 1/20 0.36
HTR6 P50406 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3099146 0.75 CYP2C19 (0.51) HSD17B10SMN1; SMN2RXFP1CYP1A2CYP2C9
SCHEMBL22374561 0.73 HRH4 (0.43) HSD17B10SMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24453540 0.70 GHSR (0.37) HSD17B10SMN1; SMN2SIRT1PARP1HTR2A
SCHEMBL27624769 0.70 NQO2 (0.43) HSD17B10SMN1; SMN2RXFP1CYP1A2NPSR1
SCHEMBL24201870 0.68 HSD17B10 (0.75) HSD17B10SMN1; SMN2RXFP1CYP1A2CYP2C9
SCHEMBL20125059 0.68 DAO (0.60) MAPTKDM4EALDH1A1HTTPARP1
SCHEMBL16065330 0.68 DAO (0.37) RXFP1CYP1A2CYP2C9CYP2C19PRNP
SCHEMBL20382321 0.68 ALDH1A1 (0.64) HSD17B10SMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL21870108 0.67 ALDH1A1 (0.38) HSD17B10SMN1; SMN2RXFP1CYP1A2CYP2C9
SCHEMBL19412656 0.67 NOS2 (0.48) SMN1; SMN2CYP1A2KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed